42,573 cases of hepatectomy in China: a multicenter retrospective investigation
- 103 Downloads
Hepatectomy is currently routinely performed in most hospitals in China. China owns the largest population of liver diseases and the biggest number of liver resection cases. A nationwide multicenter retrospective investigation involving 112 hospitals was performed, and focused on liver resection for patients with hepatocellular carcinoma (HCC). 42,573 cases of hepatectomy were enrolled, and 18,275 valid cases of liver resection for HCC patients were selected for statistical analysis. The epidemiology of HCC, distribution of hepatectomy, postoperative complications and prognosis were finally analyzed. In the 18,275 HCC patients, 81% had hepatitis B virus infection and 10% had hepatitis C virus infection. 38% of the HCC patients had normal Alphafetoprotein (AFP) level, and other 35% had an AFP level lower than 400 ng mL−1. In the study period, 97% of the hepatectomy for HCC were treated with open surgery, and 23.81% had vascular exclusion techniques. The operation time was (191.7±105.6) min, the blood loss was (546.0±562.8) mL, and blood transfusion was (543.0±1,035.2) mL. The median survival for HCC patients was 631 days, with 1-, 3-, and 5-year overall survival of 73.2%, 28.8% and 19.6%, respectively. Liver cirrhosis, multiple nodules, tumor thrombosis and high AFP level were risk factors that affect postoperative survival.
Keywordshepatectomy hepatocellular carcinoma China
Unable to display preview. Download preview PDF.
This work was supported by the State Key Project on Inflectional Disease of China (2012ZX10002016-004, 2012ZX 10002010-001-004), the Chinese Ministry of Public Health for Key Clinical Projects (439, 2010) to Prof. Xiaoping Chen, and the National Natural Science Foundation of China (81502524) to Dr. Binhao Zhang.
- Association, S.B.o.t.C.M. (2013). Expert consensus for laparoscopic liver resection (version 2013). Chin J Clin Oncol 40, 303–307.Google Scholar
- Association, S.B.o.t.C.M. (2017). Expert consensus on the option of surgical management of hepatocelluar carcinoma (2016 3rd version). Chin J Dig Surg 2017, 113–115.Google Scholar
- Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., Rodés, J., and EASL Panel of Experts on HCC. (2001). Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35, 421–430.CrossRefPubMedGoogle Scholar
- Chen, X.P. (1994). Experience in treatment of huge hepatic cancer by hepatectomy. J Hepatob Surg 2, 193–194.Google Scholar
- Chen, X.P., Qiu, F.Z., Wu, Z.D., Zhang, Z.W., Huang, Z.Y., Chen, Y.F., Zhang, B.X., He, S.Q., and Zhang, W.G. (2006b). Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13, 940–946.CrossRefPubMedGoogle Scholar
- Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., Koide, N., Adachi, W., and Amano, J. (2002). Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma11No competing interests declared. J Am College Surgeons 191, 381–388.CrossRefGoogle Scholar
- Lau, W.Y. (2002). Management of hepatocellular carcinoma. J Royal College Surgeons Edinburgh 47, 389–399.Google Scholar
- Lau, W.Y., and Lai, E.C. (2008). Hepatocellular carcinoma: current management and recent advances. Hepatob Pancreat Dis Int 7, 237–257.Google Scholar
- Vauthey, J.N., Abdalla, E.K., Doherty, D.A., Gertsch, P., Fenstermacher, M. J., Loyer, E.M., Lerut, J., Materne, R., Wang, X., Encarnacion, A., Herron, D., Mathey, C., Ferrari, G., Charnsangavej, C., Do, K.A., and Denys, A. (2002). Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8, 233–240.CrossRefPubMedGoogle Scholar